{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:56:52Z","timestamp":1790211412866,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","award":["05-4-B284-A466-22237"],"award-info":[{"award-number":["05-4-B284-A466-22237"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijcard.2015.06.160","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T13:57:04Z","timestamp":1436104624000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial"],"prefix":"10.1016","volume":"198","author":[{"given":"M.J. Pekka","family":"Raatikainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Hakalahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paavo","family":"Uusimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0294-3750","authenticated-orcid":false,"given":"Arne","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-5709","authenticated-orcid":false,"given":"H\u00e5kan","family":"Walfridsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Pehrson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Kongstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Spange","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Steen","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcard.2015.06.160_bb0005","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study","volume":"48","author":"Pappone","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.06.160_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2015.06.160_bb0015","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Jais","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.160_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcard.2015.06.160_bb0025","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.160_bb0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"B. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"issue":"21","key":"10.1016\/j.ijcard.2015.06.160_bb0035","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2015.06.160_bb0040","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/europace\/eup122","article-title":"The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation","volume":"11","author":"Jons","year":"2009","journal-title":"Europace"},{"issue":"17","key":"10.1016\/j.ijcard.2015.06.160_bb0045","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2015.06.160_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.2002.01628.x","article-title":"Is intent-to-treat analysis always (ever) enough?","volume":"54","author":"Sheiner","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.06.160_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect. Clin. Res."},{"issue":"7","key":"10.1016\/j.ijcard.2015.06.160_bb0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ijcard.2015.06.160_bb0065","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.160_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"19","key":"10.1016\/j.ijcard.2015.06.160_bb0075","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","article-title":"In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93801 procedures","volume":"128","author":"Deshmukh","year":"2013","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ijcard.2015.06.160_bb0080","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","article-title":"Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation","volume":"53","author":"Cappato","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.160_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"11","key":"10.1016\/j.ijcard.2015.06.160_bb0090","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1540-8167.2010.01798.x","article-title":"Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review","volume":"21","author":"Balk","year":"2010","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.06.160_bb0095","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.ijcard.2012.05.008","article-title":"Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis","volume":"167","author":"D'Ascenzo","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.06.160_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIRCEP.113.001182","article-title":"Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry","volume":"7","author":"Kornej","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"22","key":"10.1016\/j.ijcard.2015.06.160_bb0105","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.06.160_bb0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.160_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/europace\/eum276","article-title":"Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode","volume":"10","author":"Cosio","year":"2008","journal-title":"Europace"},{"issue":"16","key":"10.1016\/j.ijcard.2015.06.160_bb0120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/hrt.2010.194613","article-title":"Long-term outcome after catheter ablation for atrial fibrillation: safety, efficacy and impact on prognosis","volume":"96","author":"Hunter","year":"2010","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.160_bb0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/157340312803760758","article-title":"Long-term success and follow-up after atrial fibrillation ablation","volume":"8","author":"Kircher","year":"2012","journal-title":"Curr. Cardiol. Rev."},{"issue":"23","key":"10.1016\/j.ijcard.2015.06.160_bb0130","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","article-title":"Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up","volume":"122","author":"Ouyang","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2015.06.160_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacc.2010.05.061","article-title":"Catheter ablation for atrial fibrillation: are results maintained at 5years of follow-up?","volume":"57","author":"Weerasooriya","year":"2011","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731530108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731530108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T23:55:35Z","timestamp":1537487735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731530108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"alternative-id":["S016752731530108X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.06.160","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.06.160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}